Online citations, reference lists, and bibliographies.
← Back to Search

AD80, A Multikinase Inhibitor, Exhibits Antineoplastic Effects In Acute Leukemia Cellular Models Targeting The PI3K/STMN1 Axis

J. Carlos, Keli Lima, L. Costa-Lotufo, A. Leitão, J. Machado-Neto
Published 2021 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Despite the great advances in the understanding of the molecular basis of acute leukemia, very little of this knowledge has been translated into new therapies. Stathmin 1 (STMN1), a phosphoprotein that regulates microtubules dynamics, is highly expressed in acute leukemia cells and promotes cell cycle progression and proliferation. GDP366 has been described as a STMN1 and survivin inhibitor in solid tumors. This study identified structural GDP366 analogs and the cellular and molecular mechanisms underlying their suppressive effects on acute leukemia cellular models. STMN1 mRNA levels were higher in AML and ALL patients, independent of risk stratification (all p < 0.001). Cheminformatics analysis identified three structural GDP366 analogs, with AD80 more potent and effective than GSK2606414 and GW768505A. In acute leukemia cells, GDP366 and AD80 reduced cell viability and autonomous clonal growth in a dose- and/or time-dependent manner (p < 0.05) and induced apoptosis and cell cycle arrest (p < 0.05). At the molecular level, GDP366 and AD80 reduced Ki-67 (a proliferation marker) expression and S6 ribosomal protein (a PI3K/AKT/mTOR effector) phosphorylation, and induced PARP1 (an apoptosis marker) cleavage and γH2AX (a DNA damage marker) expression. GDP366 induced STMN1 phosphorylation and survivin expression, while AD80 reduced survivin and STMN1 expression. GDP366 and AD80 modulated 18 of the 84 cytoskeleton regulators-related genes. These results indicated that GDP366 and AD80 reduced the PI3K/STMN1 axis and had cytotoxic effects in acute leukemia cellular models. Our findings further highlight STMN1-mediated signaling as a putative anticancer target for acute leukemia.
This paper references
10.1016/s0021-9258(18)37630-0
Identification of a polypeptide associated with the malignant phenotype in acute leukemia.
S. Hanash (1988)
Expression of oncoprotein 18 in human leukemias and lymphomas.
G. Roos (1993)
G Roos (1993)
Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells.
S. Jeha (1996)
Antisense RNA inhibition of phosphoprotein p18 expression Invest New Drugs abrogates the transformed phenotype of leukemic cells
S Jeha (1996)
S Jeha (1996)
Antisense RNA inhibition of phosphoprotein p18 expression 1148 Invest New Drugs (2021) 39:1139–1149 abrogates the transformed phenotype of leukemic cells
S Jeha (1996)
10.1038/NM0897-917
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
G. Ambrosini (1997)
10.1182/ash-sap.2007.10
Acute myeloid leukemia.
F. Giles (2002)
10.1038/sj.onc.1207113
Survivin, versatile modulation of cell division and apoptosis in cancer
D. Altieri (2003)
10.1074/jbc.M410598200
Global Effects of BCR/ABL and TEL/PDGFRβ Expression on the Proteome and Phosphoproteome
R. Unwin (2005)
10.1074/JBC.M410598200
Global effects of BCR/ABL and TEL/PDGFRbeta expression on the proteome and phosphoproteome: identification of the Rho pathway as a target of BCR/ABL.
R. Unwin (2005)
Proteomic analysis of acute promyelocytic leukemia
M. Heye (2006)
10.1002/PMIC.200600307
Proteomic analysis of acute promyelocytic leukemia: PML‐RARα leads to decreased phosphorylation of OP18 at serine 63
A. P. Zada (2006)
10.1021/JM0603365
Comparison of shape-matching and docking as virtual screening tools.
P. Hawkins (2007)
10.1182/blood-2009-07-235358
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
H. Döhner (2010)
10.1200/JCO.2009.23.4732
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.
T. Haferlach (2010)
10.2174/1875036201004010005
Amazonia!: An Online Resource to Google and Visualize Public Human whole Genome Expression Data
Tanguy Le Carrour (2010)
10.1021/ci100031x
Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database
P. Hawkins (2010)
10.4161/cbt.9.8.11269
GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells
Xianping Shi (2010)
TL Carrour (2010)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel
H Dohner (2010)
10.1517/14728222.2011.620951
Stathmin: a protein with many tasks. New biomarker and potential target in cancer
B. Belletti (2011)
10.1007/978-1-61779-074-4_8
Acute lymphoblastic leukaemia.
C. Schwab (2011)
10.1021/jm300713s
Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK).
J. Axten (2012)
10.1038/nature11127
Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
A. Dar (2012)
10.1056/NEJMoa1301689
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
T. Ley (2013)
10.1016/j.leukres.2013.11.013
Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells.
J. Machado-Neto (2014)
10.2174/13816128113199990593
C-KIT signaling in cancer treatment.
K. Stankov (2014)
10.5483/BMBRep.2014.47.12.020
Stathmin 1 in normal and malignant hematopoiesis
J. Machado-Neto (2014)
10.18632/oncotarget.4998
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
J. Machado-Neto (2015)
10.1056/NEJMra1406184
Acute Myeloid Leukemia.
H. Döhner (2015)
10.1016/j.ejca.2015.07.018
Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia.
João Kleber Novais Pereira (2015)
10.3892/mmr.2016.5652
Overexpression of gelsolin reduces the proliferation and invasion of colon carcinoma cells
Wen-xiang Li (2016)
10.1016/J.TRECAN.2016.09.001
The Emerging Role of Cdk5 in Cancer.
Karine Pozo (2016)
10.1038/nbt.3374
Comprehensive characterization of the Published Kinase Inhibitor Set
J. Elkins (2016)
10.1182/blood-2016-03-643544
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
D. Arber (2016)
10.1126/scitranslmed.aah6144
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors
Dennis Plenker (2017)
10.1016/j.heliyon.2017.e00405
Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells
J. Machado-Neto (2017)
10.1016/j.celrep.2017.02.022
Pharmacologic Targeting of S6K1 in PTEN-Deficient Neoplasia.
Hongqi Liu (2017)
10.1038/bjc.2017.292
Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer
M. Li (2017)
10.1038/bcj.2017.53
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
T. Terwilliger (2017)
10.3892/or.2017.6145
STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway.
Wenpeng Jiang (2018)
W Jiang (2018)
10.7150/jca.28529
Lower Expression of Gelsolin in Colon Cancer and Its Diagnostic Value in Colon Cancer Patients
Zhuoyu Chen (2019)
10.1038/s41419-019-1523-3
The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitors
Mohamed Mahameed (2019)
10.1158/1535-7163.MCT-18-0571
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology
Jia Xin Yu (2019)
10.3390/cancers12010238
Cytoskeletal Proteins in Cancer and Intracellular Stress: A Therapeutic Perspective
M. S. Ong (2020)
10.1016/S0140-6736(19)33018-1
Acute lymphoblastic leukaemia
F. Malard (2020)
Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
and lymphomas
D Plenker



Semantic Scholar Logo Some data provided by SemanticScholar